Veracyte reported $1.23M in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acceleron Pharma XLRN:US $ -63662000 59K
Agenus AGEN:US $ -66395000 25.02M
Agilent A:US $ 351M 33M
Anika Therapeutics ANIK:US $ -2262000 1.28M
Arrowhead Research ARWR:US $ -31868000 3.64M
Biocept BIOC:US $ -1747780 4.41M
Bruker BRKR:US $ 89.6M 3.5M
Dicerna Pharmaceuticals DRNA:US $ -40244000 11.14M
Genmark Diagnostics GNMK:US $ -2087000 821K
Heron Therapeutics HRTX:US $ -60469000 8.36M
Illumina ILMN:US $ 187M 6M
Immunogen IMGN:US $ -27369000 1.55M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Laboratory Of America LH:US $ 750M 338.6M
Ligand Pharmaceuticals LGND:US $ 45.76M 41.04M
Luminex LMNX:US $ 13.46M 2.96M
Myriad Genetics MYGN:US $ -19000000 27.7M
Rigel Pharmaceuticals RIGL:US $ -13048000 54.8M
Sangamo Biosciences SGMO:US $ -48700000 2.4M
Siemens SIE:GR 1.72B 30M
Sonic Healthcare SHL:AU $ 925.75M 69.61M
Thermo Fisher Scientific TMO:US $ 2282M 805M
Veracyte VCYT:US $ 1.23M 11.54M
Waters WAT:US $ 195.85M 24.58M